Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] |
The tables below reflect the value of the Company's Level 1, Level 2, and Level 3 financial instruments that are measured at fair value on a recurring basis as of June 30, 2021 and December 31, 2020: June 30, 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | Description | | Level 1 | | Level 2 | | Level 3 | | Total | | | (In thousands) | Assets: | | | | | | | | | Securities, at fair value: | | | | | | | | | Agency RMBS | | $ | — | | | $ | 1,465,812 | | | $ | 9,936 | | | $ | 1,475,748 | | Non-Agency RMBS | | — | | | 70,732 | | | 114,464 | | | 185,196 | | CMBS | | — | | | 28,847 | | | 17,025 | | | 45,872 | | CLOs | | — | | | 36,550 | | | 33,989 | | | 70,539 | | Asset-backed securities, backed by consumer loans | | — | | | — | | | 69,254 | | | 69,254 | | Corporate debt securities | | — | | | 440 | | | 5,444 | | | 5,884 | | Corporate equity securities | | — | | | — | | | 8,497 | | | 8,497 | | Loans, at fair value: | | | | | | | | | Residential mortgage loans | | — | | | — | | | 1,445,651 | | | 1,445,651 | | Commercial mortgage loans | | — | | | — | | | 228,450 | | | 228,450 | | Consumer loans | | — | | | — | | | 52,016 | | | 52,016 | | Corporate loans | | — | | | — | | | 16,584 | | | 16,584 | | Investment in unconsolidated entities, at fair value | | — | | | — | | | 178,979 | | | 178,979 | | Financial derivatives–assets, at fair value: | | | | | | | | | Credit default swaps on asset-backed securities | | — | | | — | | | 303 | | | 303 | | Credit default swaps on asset-backed indices | | — | | | 1,357 | | | — | | | 1,357 | | Credit default swaps on corporate bond indices | | — | | | 200 | | | — | | | 200 | | Interest rate swaps | | — | | | 7,220 | | | — | | | 7,220 | | TBAs | | — | | | 2,028 | | | — | | | 2,028 | | Total return swaps | | — | | | — | | | 520 | | | 520 | | Options | | — | | | 294 | | | — | | | 294 | | Warrants | | — | | | 2 | | | — | | | 2 | | Futures | | 659 | | | — | | | — | | | 659 | | Forwards | | — | | | 445 | | | — | | | 445 | | Total assets | | $ | 659 | | | $ | 1,613,927 | | | $ | 2,181,112 | | | $ | 3,795,698 | | Liabilities: | | | | | | | | | Securities sold short, at fair value: | | | | | | | | | Government debt | | $ | — | | | $ | (145,152) | | | $ | — | | | $ | (145,152) | | Corporate debt securities | | — | | | (222) | | | — | | | (222) | | Financial derivatives–liabilities, at fair value: | | | | | | | | | Credit default swaps on asset-backed indices | | — | | | (91) | | | — | | | (91) | | Credit default swaps on corporate bonds | | — | | | (384) | | | — | | | (384) | | Credit default swaps on corporate bond indices | | — | | | (2,616) | | | — | | | (2,616) | | Interest rate swaps | | — | | | (10,540) | | | — | | | (10,540) | | TBAs | | — | | | (329) | | | — | | | (329) | | Futures | | (155) | | | — | | | — | | | (155) | | Total return swaps | | — | | | — | | | (56) | | | (56) | | Other secured borrowings, at fair value | | — | | | — | | | (1,003,037) | | | (1,003,037) | | Total liabilities | | $ | (155) | | | $ | (159,334) | | | $ | (1,003,093) | | | $ | (1,162,582) | |
December 31, 2020: | | | | | | | | | | | | | | | | | | | | | | | | | | | Description | | Level 1 | | Level 2 | | Level 3 | | Total | | | (In thousands) | Assets: | | | | | | | | | Securities, at fair value: | | | | | | | | | Agency RMBS | | $ | — | | | $ | 947,780 | | | $ | 11,663 | | | $ | 959,443 | | Non-Agency RMBS | | — | | | 76,276 | | | 127,838 | | | 204,114 | | CMBS | | — | | | 54,505 | | | 63,148 | | | 117,653 | | CLOs | | — | | | 70,171 | | | 111,100 | | | 181,271 | | Asset-backed securities, backed by consumer loans | | — | | | — | | | 44,925 | | | 44,925 | | Corporate debt securities | | — | | | 1,107 | | | 4,082 | | | 5,189 | | Corporate equity securities | | — | | | — | | | 1,590 | | | 1,590 | | Loans, at fair value: | | | | | | | | | Residential mortgage loans | | — | | | — | | | 1,187,069 | | | 1,187,069 | | Commercial mortgage loans | | — | | | — | | | 213,031 | | | 213,031 | | Consumer loans | | — | | | — | | | 47,525 | | | 47,525 | | Corporate loans | | — | | | — | | | 5,855 | | | 5,855 | | Investment in unconsolidated entities, at fair value | | — | | | — | | | 141,620 | | | 141,620 | | Financial derivatives–assets, at fair value: | | | | | | | | | Credit default swaps on asset-backed securities | | — | | | — | | | 347 | | | 347 | | Credit default swaps on asset-backed indices | | — | | | 2,184 | | | — | | | 2,184 | | Credit default swaps on corporate bond indices | | — | | | 3,420 | | | — | | | 3,420 | | Interest rate swaps | | — | | | 8,519 | | | — | | | 8,519 | | TBAs | | — | | | 962 | | | — | | | 962 | | Total return swaps | | — | | | — | | | 9 | | | 9 | | Warrants | | — | | | 36 | | | — | | | 36 | | Futures | | 2 | | | — | | | — | | | 2 | | Total assets | | $ | 2 | | | $ | 1,164,960 | | | $ | 1,959,802 | | | $ | 3,124,764 | | Liabilities: | | | | | | | | | Securities sold short, at fair value: | | | | | | | | | Government debt | | $ | — | | | $ | (38,424) | | | $ | — | | | $ | (38,424) | | Corporate debt securities | | — | | | (218) | | | — | | | (218) | | Financial derivatives–liabilities, at fair value: | | | | | | | | | Credit default swaps on asset-backed indices | | — | | | (130) | | | — | | | (130) | | Credit default swaps on corporate bonds | | — | | | (747) | | | — | | | (747) | | Credit default swaps on corporate bond indices | | — | | | (6,438) | | | — | | | (6,438) | | Interest rate swaps | | — | | | (15,174) | | | — | | | (15,174) | | TBAs | | — | | | (925) | | | — | | | (925) | | Futures | | (376) | | | — | | | — | | | (376) | | Forwards | | — | | | (279) | | | — | | | (279) | | Total return swaps | | — | | | — | | | (484) | | | (484) | | Other secured borrowings, at fair value | | — | | | — | | | (754,921) | | | (754,921) | | Total liabilities | | $ | (376) | | | $ | (62,335) | | | $ | (755,405) | | | $ | (818,116) | |
|
Schedule of Significant Unobservable Inputs, Qualitative Information |
The following tables identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of June 30, 2021 and December 31, 2020: June 30, 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average | Description | | | | | Min | | Max | | | | (In thousands) | | | | | | | | | | | Non-Agency RMBS | | $ | 71,514 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 0.91 | | | $ | 210.00 | | | $ | 81.90 | | | | 42,950 | | | Discounted Cash Flows | | | | | | | | | | | 114,464 | | | | | Yield(1) | | 0.6 | % | | 42.5 | % | | 7.5 | % | | | | | | | Projected Collateral Prepayments | | — | % | | 73.0 | % | | 40.5 | % | | | | | | | Projected Collateral Losses | | — | % | | 79.7 | % | | 13.2 | % | | | | | | | Projected Collateral Recoveries | | — | % | | 71.9 | % | | 23.2 | % | Non-Agency CMBS | | 13,671 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 4.50 | | | $ | 72.22 | | | $ | 43.31 | | | | 3,354 | | | Discounted Cash Flows | | | | | | | | | | | 17,025 | | | | | Yield | | 5.5 | % | | 22.6 | % | | 10.3 | % | | | | | | | Projected Collateral Losses | | 0.2 | % | | 3.8 | % | | 1.9 | % | | | | | | | Projected Collateral Recoveries | | 88.7 | % | | 98.0 | % | | 93.6 | % | CLOs | | 25,851 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 10.00 | | | $ | 93.80 | | | $ | 49.88 | | | | 8,138 | | | Discounted Cash Flows | | | | | | | | | | | 33,989 | | | | | Yield | | 7.1 | % | | 92.3 | % | | 25.9 | % | | | | | | | Projected Collateral Prepayments | | 72.2 | % | | 98.8 | % | | 89.6 | % | | | | | | | Projected Collateral Losses | | 1.0 | % | | 20.9 | % | | 5.7 | % | | | | | | | Projected Collateral Recoveries | | 0.2 | % | | 7.5 | % | | 3.6 | % | Agency interest only RMBS | | 5,822 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 0.64 | | | $ | 20.85 | | | $ | 6.52 | | | | 4,114 | | | Option Adjusted Spread ("OAS") | | | | | | | | | | | 9,936 | | | | | LIBOR OAS(2)(3) | | 160 | | | 11,771 | | | 1,165 | | | | | | | | Projected Collateral Prepayments | | 9.7 | % | | 100.0 | % | | 69.3 | % | ABS backed by consumer loans | | 75 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 97.39 | | | $ | 98.82 | | | $ | 97.97 | | | | 69,179 | | | Discounted Cash Flows | | | | | | | | | | | 69,254 | | | | | Yield | | 6.1 | % | | 77.2 | % | | 15.4 | % | | | | | | | Projected Collateral Prepayments | | 0.9 | % | | 11.8 | % | | 8.9 | % | | | | | | | Projected Collateral Losses | | 3.7 | % | | 37.6 | % | | 20.3 | % | Corporate debt and equity | | 13,941 | | | Discounted Cash Flows | | Yield | | 2.6 | % | | 11.9 | % | | 9.4 | % | Performing and re-performing residential mortgage loans | | 356,074 | | | Discounted Cash Flows | | Yield | | 0.5 | % | | 34.0 | % | | 4.9 | % | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average | Description | | | | | Min | | Max | | (continued) | | (In thousands) | | | | | | | | | | | Securitized residential mortgage loans(4)(5) | | $ | 1,031,653 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 0.64 | | | $ | 103.53 | | | $ | 99.20 | | | | 31,408 | | | Discounted Cash Flows | | | | | | | | | | | 1,063,061 | | | | | Yield | | 0.9 | % | | 7.3 | % | | 3.8 | % | Non-performing residential mortgage loans | | 26,516 | | | Discounted Cash Flows | | Yield | | 2.1 | % | | 37.3 | % | | 11.7 | % | | | | | | | Recovery Amount | | — | % | | 169.2 | % | | 31.3 | % | | | | | | | Months to Resolution | | 5.8 | | | 73.0 | | | 30.1 | | Performing commercial mortgage loans | | 192,023 | | | Discounted Cash Flows | | Yield | | 6.1 | % | | 10.8 | % | | 8.3 | % | Non-performing commercial mortgage loans | | 36,427 | | | Discounted Cash Flows | | Yield | | 6.6 | % | | 9.9 | % | | 8.3 | % | | | | | | | Recovery Amount | | 96.5 | % | | 100.0 | % | | 99.6 | % | | | | | | | Months to Resolution | | 1.8 | | 5.9 | | 3.4 | Consumer loans | | 52,016 | | | Discounted Cash Flows | | Yield | | 1.3 | % | | 56.0 | % | | 9.5 | % | | | | | | | Projected Collateral Prepayments | | 0.4 | % | | 32.6 | % | | 15.1 | % | | | | | | | Projected Collateral Losses | | 0.9 | % | | 37.1 | % | | 9.6 | % | Corporate loans | | 13,496 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 100.00 | | | $ | 100.00 | | | $ | 100.00 | | | | 3,088 | | | Discounted Cash Flows | | | | | | | | | | | 16,584 | | | | | Yield | | 3.0 | % | | 22.5 | % | | 18.6 | % | Investment in unconsolidated entities - Loan originators | | 93,092 | | | Enterprise Value | | Equity Price-to-Book(6) | | 1.2x | | 1.4x | | 1.2x | Investment in unconsolidated entities - Other | | 75,820 | | | Enterprise Value | | Net Asset Value | | n/a | | n/a | | n/a | Investment in unconsolidated entities - Loan originators | | 10,067 | | | Recent Transactions | | Transaction Price | | n/a | | n/a | | n/a | | | 178,979 | | | | | | | | | | | | Total return swaps—asset | | 520 | | | Discounted Cash Flows | | Yield | | 19.9 | % | | 21.2 | % | | 21.2 | % | Credit default swaps on asset-backed securities | | 303 | | | Net Discounted Cash Flows | | Projected Collateral Prepayments | | 30.8 | % | | 40.9 | % | | 38.6 | % | | | | | | | Projected Collateral Losses | | 5.2 | % | | 8.8 | % | | 6.8 | % | | | | | | | Projected Collateral Recoveries | | 11.7 | % | | 16.7 | % | | 12.8 | % | Total return swaps—liability | | (56) | | | Discounted Cash Flows | | Yield | | 19.9% | | 19.9% | | 19.9% | Other secured borrowings, at fair value(4) | | (1,003,037) | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 97.68 | | | $ | 103.53 | | | $ | 101.10 | | | | | | | | Yield | | 1.9% | | 3.2% | | 2.4% | | | | | | | Projected Collateral Prepayments | | —% | | 97.4% | | 65.9% |
(1)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $1.5 million. Including these securities the weighted average yield was 7.3%. (2)Shown in basis points. (3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $3.0 million. Including these securities the weighted average was 613 basis points. (4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2. (5)Includes $12.9 million of non-performing securitized residential mortgage loans. (6)Represents an estimation of where market participants might value an enterprise on a price-to-book basis. December 31, 2020: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average | Description | | | | | Min | | Max | | | | (In thousands) | | | | | | | | | | | Non-Agency RMBS | | $ | 70,619 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 9.53 | | | $ | 204.61 | | | $ | 85.70 | | | | 57,219 | | | Discounted Cash Flows | | | | | | | | | | | 127,838 | | | | | Yield(1) | | 0.7 | % | | 52.6 | % | | 7.4 | % | | | | | | | Projected Collateral Prepayments | | — | % | | 99.1 | % | | 45.3 | % | | | | | | | Projected Collateral Losses | | 0.4 | % | | 72.6 | % | | 18.4 | % | | | | | | | Projected Collateral Recoveries | | — | % | | 79.1 | % | | 16.8 | % | Non-Agency CMBS | | 53,199 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 4.79 | | | $ | 98.00 | | | $ | 65.20 | | | | 9,949 | | | Discounted Cash Flows | | | | | | | | | | | 63,148 | | | | | Yield | | 3.7 | % | | 26.3 | % | | 8.7 | % | | | | | | | Projected Collateral Losses | | 0.7 | % | | 10.7 | % | | 3.6 | % | | | | | | | Projected Collateral Recoveries | | 72.4 | % | | 96.1 | % | | 90.6 | % | CLOs | | 102,910 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 2.00 | | | $ | 330.00 | | | $ | 88.66 | | | | 8,190 | | | Discounted Cash Flows | | | | | | | | | | | 111,100 | | | | | Yield | | 3.4 | % | | 35.4 | % | | 10.5 | % | | | | | | | Projected Collateral Prepayments | | 41.2 | % | | 97.7 | % | | 65.7 | % | | | | | | | Projected Collateral Losses | | 1.7 | % | | 28.9 | % | | 11.2 | % | | | | | | | Projected Collateral Recoveries | | 0.6 | % | | 15.2 | % | | 7.9 | % | Agency interest only RMBS | | 4,844 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 1.91 | | | $ | 18.91 | | | $ | 8.38 | | | | 6,819 | | | Option Adjusted Spread ("OAS") | | | | | | | | | | | 11,663 | | | | | LIBOR OAS(2)(3) | | 297 | | | 2,886 | | | 914 | | | | | | | | Projected Collateral Prepayments | | 8.3 | % | | 100.0 | % | | 75.9 | % | ABS backed by consumer loans | | 97 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 96.51 | | | $ | 98.43 | | | $ | 97.33 | | | | 44,828 | | | Discounted Cash Flows | | | | | | | | | | | 44,925 | | | | | Yield | | 12.6 | % | | 27.5 | % | | 15.6 | % | | | | | | | Projected Collateral Prepayments | | 0.0 | % | | 11.6 | % | | 7.7 | % | | | | | | | Projected Collateral Losses | | 1.0 | % | | 21.1 | % | | 17.1 | % | Corporate debt and equity | | 5,672 | | | Discounted Cash Flows | | Yield | | 8.1 | % | | 10.8 | % | | 9.7 | % | Performing and re-performing residential mortgage loans | | 338,265 | | | Discounted Cash Flows | | Yield | | 2.5 | % | | 28.5 | % | | 5.4 | % | | | 15,659 | | | Recent Transactions | | Transaction Price | | $ | 60.00 | | | $ | 103.88 | | | $ | 103.44 | | | | 353,924 | | | | | | | | | | | | Securitized residential mortgage loans(4)(5) | | $ | 783,162 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 5.34 | | | $ | 105.61 | | | $ | 100.22 | | | | 18,182 | | | Discounted Cash Flows | | | | | | | | | | | 801,343 | | | | | Yield | | — | % | | 38.7 | % | | 4.4 | % | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value | | Valuation Technique | | Unobservable Input | | Range | | Weighted Average | Description | | | | | Min | | Max | | (Continued) | | (In thousands) | | | | | | | | | | | Non-performing residential mortgage loans | | 31,802 | | | Discounted Cash Flows | | Yield | | 1.2 | % | | 41.0 | % | | 12.1 | % | | | | | | | Recovery Amount | | 0.9 | % | | 1713.0 | % | | 30.6 | % | | | | | | | Months to Resolution | | 0.0 | | | 106.6 | | | 30.0 | | Performing commercial mortgage loans | | 181,545 | | | Discounted Cash Flows | | Yield | | 3.7 | % | | 9.7 | % | | 8.1 | % | Non-performing commercial mortgage loans | | 31,486 | | | Discounted Cash Flows | | Yield | | 8.6 | % | | 14.6 | % | | 10.8 | % | | | | | | | Recovery Amount | | 100.0 | % | | 102.4 | % | | 100.8 | % | | | | | | | Months to Resolution | | 1.8 | | 5.8 | | 3.7 | Consumer loans | | 47,525 | | | Discounted Cash Flows | | Yield | | 7.8 | % | | 28.1 | % | | 11.2 | % | | | | | | | Projected Collateral Prepayments | | 0.0 | % | | 36.0 | % | | 17.3 | % | | | | | | | Projected Collateral Losses | | 0.9 | % | | 86.6 | % | | 9.4 | % | Corporate loans | | 5,855 | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 100.00 | | | $ | 100.00 | | | $ | 100.00 | | | | | | | | Yield | | 21.1 | % | | 21.1 | % | | 21.1 | % | Investment in unconsolidated entities—Loan Originators(6) | | 79,536 | | | Enterprise Value | | Equity Price-to-Book(7) | | 1.4x | | 6.2x | | 1.8x | Investment in unconsolidated entities—Other(6) | | 62,084 | | | Enterprise Value | | Net Asset Value | | n/a | | n/a | | n/a | | | 141,620 | | | | | | | | | | | | Total return swaps—asset | | 9 | | | Discounted Cash Flows | | Yield | | 22.0 | % | | 22.0 | % | | 22.0 | % | Credit default swaps on asset-backed securities | | 347 | | | Net Discounted Cash Flows | | Projected Collateral Prepayments | | 32.7 | % | | 39.7 | % | | 38.1 | % | | | | | | | Projected Collateral Losses | | 6.6 | % | | 10.8 | % | | 8.9 | % | | | | | | | Projected Collateral Recoveries | | 13.9 | % | | 18.1 | % | | 15.6 | % | Total return swaps—liability | | (484) | | | Discounted Cash Flows | | Yield | | 16.8% | | 16.8% | | 16.8% | Other secured borrowings, at fair value(4) | | (754,921) | | | Market Quotes | | Non Binding Third-Party Valuation | | $ | 85.37 | | | $ | 105.61 | | | $ | 102.04 | | | | | | | | Yield | | 1.6% | | 3.0% | | 2.6% | | | | | | | Projected Collateral Prepayments | | —% | | 75.3% | | 48.7% |
(1)For the range minimum, the range maximum, and the weighted average yield, excludes non-Agency RMBS with a negative yield, with a total fair value of $0.3 million. Including these securities the weighted average yield was 7.3%. (2)Shown in basis points. (3)For range minimum, range maximum, and the weighted average of LIBOR OAS, excludes Agency interest only securities with a negative LIBOR OAS, with a total fair value of $4.5 million. Including these securities the weighted average was 396 basis points. (4)Securitized residential mortgage loans and Other secured borrowings, at fair value, represent financial assets and liabilities of the Company's CFEs as discussed in Note 2. (5)Includes $26.4 million of non-performing securitized residential mortgage loans. (6)Conformed to current period presentation. (7)Represent an estimation of where market participants might value an enterprise on a price-to-book basis.
|
Fair Value Measurement Using Significant Unobservable Inputs |
The tables below includes a roll-forward of the Company's financial instruments for the three- and six-month periods ended June 30, 2021 and 2020 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy. Three-Month Period Ended June 30, 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands) | Beginning Balance as of March 31, 2021 | | Accreted Discounts / (Amortized Premiums) | | Net Realized Gain/ (Loss) | | Change in Net Unrealized Gain/(Loss) | | Purchases/Payments(1) | | Sales/Issuances(2) | | Transfers Into Level 3 | | Transfers Out of Level 3 | | Ending Balance as of June 30, 2021 | Assets: | | | | | | | | | | | | | | | | | | Securities, at fair value: | | | | | | | | | | | | | | | | | | Agency RMBS | $ | 17,402 | | | $ | (833) | | | $ | 1,510 | | | $ | (1,389) | | | $ | — | | | $ | (4,528) | | | $ | 1,897 | | | $ | (4,123) | | | $ | 9,936 | | Non-Agency RMBS | 127,329 | | | 604 | | | 2,576 | | | (137) | | | 1,782 | | | (14,497) | | | 4,299 | | | (7,492) | | | 114,464 | | CMBS | 17,294 | | | (13) | | | — | | | 1,249 | | | — | | | — | | | 3,353 | | | (4,858) | | | 17,025 | | CLOs | 37,585 | | | 272 | | | (2,497) | | | 9,155 | | | 140 | | | — | | | 4,257 | | | (14,923) | | | 33,989 | | Asset-backed securities backed by consumer loans | 59,473 | | | (1,326) | | | 146 | | | (1,098) | | | 21,478 | | | (9,419) | | | — | | | — | | | 69,254 | | Corporate debt securities | 4,761 | | | — | | | 47 | | | 177 | | | 591 | | | (132) | | | — | | | — | | | 5,444 | | Corporate equity securities | 4,120 | | | — | | | — | | | 1,711 | | | 2,666 | | | — | | | — | | | — | | | 8,497 | | Loans, at fair value: | | | | | | | | | | | | | | | | | | Residential mortgage loans | 1,280,637 | | | (3,240) | | | 267 | | | (528) | | | 327,697 | | | (159,182) | | | — | | | — | | | 1,445,651 | | Commercial mortgage loans | 235,948 | | | 15 | | | (130) | | | 334 | | | 90,332 | | | (98,049) | | | — | | | — | | | 228,450 | | Consumer loans | 52,705 | | | (1,993) | | | (11) | | | 129 | | | 9,319 | | | (8,133) | | | — | | | — | | | 52,016 | | Corporate loan | 13,226 | | | — | | | — | | | — | | | 3,360 | | | (2) | | | — | | | — | | | 16,584 | | Investments in unconsolidated entities, at fair value | 147,684 | | | — | | | 33 | | | 18,569 | | | 69,464 | | | (56,771) | | | — | | | — | | | 178,979 | | Financial derivatives–assets, at fair value: | | | | | | | | | | | | | | | | | | Credit default swaps on asset-backed securities | 320 | | | — | | | 16 | | | (17) | | | 3 | | | (19) | | | — | | | — | | | 303 | | Total return swaps | 2 | | | — | | | — | | | 518 | | | — | | | — | | | — | | | — | | | 520 | | Total assets, at fair value | $ | 1,998,486 | | | $ | (6,514) | | | $ | 1,957 | | | $ | 28,673 | | | $ | 526,832 | | | $ | (350,732) | | | $ | 13,806 | | | $ | (31,396) | | | $ | 2,181,112 | | Liabilities: | | | | | | | | | | | | | | | | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | | | | | | | | | Total return swaps | $ | (338) | | | $ | — | | | $ | (860) | | | $ | 282 | | | $ | 860 | | | $ | — | | | $ | — | | | $ | — | | | $ | (56) | | Other secured borrowings, at fair value | (911,256) | | | — | | | — | | | 2,005 | | | 230,853 | | | (324,639) | | | — | | | — | | | (1,003,037) | | Total liabilities, at fair value | $ | (911,594) | | | $ | — | | | $ | (860) | | | $ | 2,287 | | | $ | 231,713 | | | $ | (324,639) | | | $ | — | | | $ | — | | | $ | (1,003,093) | |
(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities. (2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities. All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2021, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended June 30, 2021. For Level 3 financial instruments held by the Company at June 30, 2021, change in net unrealized gain (loss) of $10.4 million, $0.1 million, $16.4 million, $0.4 million, $0.3 million, and $2.0 million, for the three-month period ended June 30, 2021 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively. At June 30, 2021, the Company transferred $31.4 million of assets from Level 3 to Level 2 and $13.8 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. Three-Month Period Ended June 30, 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands) | Beginning Balance as of March 31, 2020 | | Accreted Discounts / (Amortized Premiums) | | Net Realized Gain/ (Loss) | | Change in Net Unrealized Gain/(Loss) | | Purchases/Payments(1) | | Sales/Issuances(2) | | Transfers Into Level 3 | | Transfers Out of Level 3 | | Ending Balance as of June 30, 2020 | Assets: | | | | | | | | | | | | | | | | | | Securities, at fair value: | | | | | | | | | | | | | | | | | | Agency RMBS | $ | 20,981 | | | $ | (1,525) | | | $ | (1) | | | $ | (592) | | | $ | 3,448 | | | $ | — | | | $ | 393 | | | $ | (9,797) | | | $ | 12,907 | | Non-Agency RMBS | 94,197 | | | 413 | | | 444 | | | 3,282 | | | 26,811 | | | (10,744) | | | 20,959 | | | (6,755) | | | 128,607 | | CMBS | 20,276 | | | 187 | | | (2,253) | | | 3,199 | | | 2,966 | | | (3,750) | | | 47,397 | | | (2,327) | | | 65,695 | | CLOs | 43,804 | | | (236) | | | (12,850) | | | 4,806 | | | 73 | | | — | | | 100,869 | | | — | | | 136,466 | | Asset-backed securities backed by consumer loans | 54,627 | | | (1,104) | | | (46) | | | (306) | | | 1,274 | | | (6,504) | | | — | | | — | | | 47,941 | | Corporate debt securities | 610 | | | — | | | 208 | | | 578 | | | 3,411 | | | (2,856) | | | — | | | — | | | 1,951 | | Corporate equity securities | 712 | | | — | | | 7 | | | 319 | | | 58 | | | (12) | | | — | | | — | | | 1,084 | | Loans, at fair value: | | | | | | | | | | | | | | | | | | Residential mortgage loans | 939,372 | | | (1,948) | | | (781) | | | 15,660 | | | 70,163 | | | (74,019) | | | — | | | — | | | 948,447 | | Commercial mortgage loans | 303,300 | | | 97 | | | (761) | | | 195 | | | 1,159 | | | (8,494) | | | — | | | — | | | 295,496 | | Consumer loans | 194,803 | | | (7,901) | | | (11) | | | 413 | | | 15,218 | | | (35,841) | | | — | | | — | | | 166,681 | | Corporate loan | 6,114 | | | — | | | — | | | — | | | 113 | | | — | | | — | | | — | | | 6,227 | | Investments in unconsolidated entities, at fair value | 65,397 | | | — | | | — | | | 5,643 | | | 1,933 | | | (420) | | | — | | | — | | | 72,553 | | Financial derivatives–assets, at fair value: | | | | | | | | | | | | | | | | | | Credit default swaps on asset-backed securities | 353 | | | — | | | 38 | | | — | | | 21 | | | (59) | | | — | | | — | | | 353 | | Total return swaps | 37 | | | — | | | 51 | | | 405 | | | — | | | (51) | | | — | | | — | | | 442 | | Total assets, at fair value | $ | 1,744,583 | | | $ | (12,017) | | | $ | (15,955) | | | $ | 33,602 | | | $ | 126,648 | | | $ | (142,750) | | | $ | 169,618 | | | $ | (18,879) | | | $ | 1,884,850 | | Liabilities: | | | | | | | | | | | | | | | | | | Financial derivatives–assets, at fair value: | | | | | | | | | | | | | | | | | | Total return swaps | $ | (839) | | | $ | — | | | $ | (536) | | | $ | 762 | | | $ | 494 | | | $ | 42 | | | $ | — | | | $ | — | | | $ | (77) | | Other secured borrowings, at fair value | (549,668) | | | — | | | — | | | (1,481) | | | 41,553 | | | (233,092) | | | — | | | — | | | (742,688) | | Total liabilities, at fair value | $ | (550,507) | | | $ | — | | | $ | (536) | | | $ | (719) | | | $ | 42,047 | | | $ | (233,050) | | | $ | — | | | $ | — | | | $ | (742,765) | |
(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities. (2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities. All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2020, as well as Level 3 financial instruments disposed of by the Company during the three-month period ended June 30, 2020. For Level 3 financial instruments held by the Company at June 30, 2020, change in net unrealized gain (loss) of $9.3 million, $16.3 million, $5.5 million, $0.4 million, $0.8 million, and $(1.5) million, for the three-month period ended June 30, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively. At June 30, 2020, the Company transferred $18.9 million of assets from Level 3 to Level 2 and $169.6 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. At June 30, 2020, there was a decrease in the availability of sufficient observable inputs to meet Level 2 criteria due to market volatility, dislocations in the financial markets, and illiquidity, resulting from the effects of the COVID-19 pandemic. Six-Month Period Ended June 30, 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands) | Beginning Balance as of December 31, 2020 | | Accreted Discounts / (Amortized Premiums) | | Net Realized Gain/ (Loss) | | Change in Net Unrealized Gain/(Loss) | | Purchases/Payments(1) | | Sales/Issuances(2) | | Transfers Into Level 3 | | Transfers Out of Level 3 | | Ending Balance as of June 30, 2021 | Assets: | | | | | | | | | | | | | | | | | | Securities, at fair value: | | | | | | | | | | | | | | | | | | Agency RMBS | $ | 11,663 | | | $ | (1,779) | | | $ | 959 | | | $ | (1,571) | | | $ | 555 | | | $ | (1,533) | | | $ | 4,567 | | | $ | (2,925) | | | $ | 9,936 | | Non-Agency RMBS | 127,838 | | | 1,248 | | | 2,351 | | | (740) | | | 22,392 | | | (33,076) | | | 5,834 | | | (11,383) | | | 114,464 | | CMBS | 63,148 | | | 319 | | | 1,931 | | | 5,029 | | | — | | | (41,088) | | | — | | | (12,314) | | | 17,025 | | CLOs | 111,100 | | | 1,240 | | | (1,754) | | | 16,208 | | | 104 | | | (70,002) | | | 1,604 | | | (24,511) | | | 33,989 | | Asset-backed securities backed by consumer loans | 44,925 | | | (1,983) | | | 179 | | | (1,583) | | | 45,812 | | | (18,096) | | | — | | | — | | | 69,254 | | Corporate debt securities | 4,082 | | | — | | | 227 | | | 183 | | | 1,617 | | | (665) | | | — | | | — | | | 5,444 | | Corporate equity securities | 1,590 | | | — | | | (385) | | | 2,315 | | | 4,977 | | | — | | | — | | | — | | | 8,497 | | Loans, at fair value: | | | | | | | | | | | | | | | | | | Residential mortgage loans | 1,187,069 | | | (5,711) | | | 462 | | | 1,686 | | | 549,778 | | | (287,633) | | | — | | | — | | | 1,445,651 | | Commercial mortgage loans | 213,031 | | | 24 | | | 306 | | | 70 | | | 147,499 | | | (132,480) | | | — | | | — | | | 228,450 | | Consumer loans | 47,525 | | | (3,836) | | | (1,276) | | | 457 | | | 26,068 | | | (16,922) | | | — | | | — | | | 52,016 | | Corporate loan | 5,855 | | | — | | | — | | | — | | | 10,731 | | | (2) | | | — | | | — | | | 16,584 | | Investments in unconsolidated entities, at fair value | 141,620 | | | — | | | 161 | | | 25,076 | | | 82,333 | | | (70,211) | | | — | | | — | | | 178,979 | | Financial derivatives–assets, at fair value: | | | | | | | | | | | | | | | | | | Credit default swaps on asset-backed securities | 347 | | | — | | | 42 | | | (44) | | | 7 | | | (49) | | | — | | | — | | | 303 | | Total return swaps | 9 | | | — | | | 141 | | | 512 | | | — | | | (142) | | | — | | | — | | | 520 | | Total assets, at fair value | $ | 1,959,802 | | | $ | (10,478) | | | $ | 3,344 | | | $ | 47,598 | | | $ | 891,873 | | | $ | (671,899) | | | $ | 12,005 | | | $ | (51,133) | | | $ | 2,181,112 | | Liabilities: | | | | | | | | | | | | | | | | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | | | | | | | | | Total return swaps | $ | (484) | | | $ | — | | | $ | (1,360) | | | $ | 428 | | | $ | 1,360 | | | $ | — | | | $ | — | | | $ | — | | | $ | (56) | | Other secured borrowings, at fair value | (754,921) | | | — | | | — | | | 3,248 | | | 323,783 | | | (575,147) | | | — | | | — | | | (1,003,037) | | Total liabilities, at fair value | $ | (755,405) | | | $ | — | | | $ | (1,360) | | | $ | 3,676 | | | $ | 325,143 | | | $ | (575,147) | | | $ | — | | | $ | — | | | $ | (1,003,093) | |
(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities. (2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities. All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2021, as well as Level 3 financial instruments disposed of by the Company during the six-month period ended June 30, 2021. For Level 3 financial instruments held by the Company at June 30, 2021, change in net unrealized gain (loss) of $11.9 million, $2.3 million, $22.7 million, $0.5 million, $0.4 million, and $3.2 million, for the six-month period ended June 30, 2021 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively. At June 30, 2021, the Company transferred $51.1 million of assets from Level 3 to Level 2 and $12.0 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. Six-Month Period Ended June 30, 2020 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In thousands) | Beginning Balance as of December 31, 2019 | | Accreted Discounts / (Amortized Premiums) | | Net Realized Gain/ (Loss) | | Change in Net Unrealized Gain/(Loss) | | Purchases/ Payments(1) | | Sales/ Issuances(2) | | Transfers Into Level 3 | | Transfers Out of Level 3 | | Ending Balance as of June 30, 2020 | Assets: | | | | | | | | | | | | | | | | | | Securities, at fair value: | | | | | | | | | | | | | | | | | | Agency RMBS | $ | 19,904 | | | $ | (3,245) | | | $ | (2) | | | $ | 2,163 | | | $ | 5,660 | | | $ | — | | | $ | 411 | | | $ | (11,984) | | | $ | 12,907 | | Non-Agency RMBS | 89,581 | | | 510 | | | 406 | | | (7,809) | | | 62,724 | | | (27,817) | | | 15,281 | | | (4,269) | | | 128,607 | | CMBS | 29,805 | | | 433 | | | (867) | | | (8,279) | | | 40,235 | | | (32,289) | | | 44,886 | | | (8,229) | | | 65,695 | | CLOs | 44,979 | | | (41) | | | (7,518) | | | (28,099) | | | 61,933 | | | (1,769) | | | 69,513 | | | (2,532) | | | 136,466 | | Asset-backed securities backed by consumer loans | 48,610 | | | (2,148) | | | (196) | | | (2,666) | | | 17,545 | | | (13,204) | | | — | | | — | | | 47,941 | | Corporate debt securities | 1,113 | | | — | | | 208 | | | 483 | | | 3,421 | | | (3,274) | | | — | | | — | | | 1,951 | | Corporate equity securities | 1,394 | | | — | | | 7 | | | (668) | | | 363 | | | (12) | | | — | | | — | | | 1,084 | | Loans, at fair value: | | | | | | | | | | | | | | | | | | Residential mortgage loans | 932,203 | | | (2,406) | | | (576) | | | (8,663) | | | 201,233 | | | (173,344) | | | — | | | — | | | 948,447 | | Commercial mortgage loans | 274,759 | | | 96 | | | 99 | | | (134) | | | 88,727 | | | (68,051) | | | — | | | — | | | 295,496 | | Consumer loans | 186,954 | | | (15,371) | | | 15 | | | (5,338) | | | 76,318 | | | (75,897) | | | — | | | — | | | 166,681 | | Corporate loan | 18,510 | | | — | | | — | | | — | | | 217 | | | (12,500) | | | — | | | — | | | 6,227 | | Investment in unconsolidated entities, at fair value | 71,850 | | | — | | | — | | | (854) | | | 14,216 | | | (12,659) | | | — | | | — | | | 72,553 | | Financial derivatives–assets, at fair value: | | | | | | | | | | | | | | | | | | Credit default swaps on asset-backed securities | 993 | | | — | | | (956) | | | 916 | | | 26 | | | (626) | | | — | | | — | | | 353 | | Total return swaps | 620 | | | — | | | 242 | | | (178) | | | — | | | (242) | | | — | | | — | | | 442 | | Total assets, at fair value | $ | 1,721,275 | | | $ | (22,172) | | | $ | (9,138) | | | $ | (59,126) | | | $ | 572,618 | | | $ | (421,684) | | | $ | 130,091 | | | $ | (27,014) | | | $ | 1,884,850 | | Liabilities: | | | | | | | | | | | | | | | | | | Financial derivatives–liabilities, at fair value: | | | | | | | | | | | | | | | | | | Total return swaps | $ | (436) | | | $ | — | | | $ | (504) | | | $ | 359 | | | $ | 504 | | | $ | — | | | $ | — | | | $ | — | | | $ | (77) | | Other secured borrowings, at fair value | (594,396) | | | — | | | — | | | (1,457) | | | 86,257 | | | (233,092) | | | — | | | — | | | (742,688) | | Total liabilities, at fair value | $ | (594,832) | | | $ | — | | | $ | (504) | | | $ | (1,098) | | | $ | 86,761 | | | $ | (233,092) | | | $ | — | | | $ | — | | | $ | (742,765) | |
(1)For Investments in unconsolidated entities, at fair value, amount represents contributions to investments in unconsolidated entities. (2)For Investments in unconsolidated entities, at fair value, amount represents distributions from investments in unconsolidated entities. All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Condensed Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at June 30, 2020, as well as Level 3 financial instruments disposed of by the Company during the six-month period ended June 30, 2020. For Level 3 financial instruments held by the Company at June 30, 2020, change in net unrealized gain (loss) of $(87.8) million, $(14.1) million, $(1.1) million, $0.9 million, $(0.1) million, and $(1.5) million, for the six-month period ended June 30, 2020 relate to securities, loans, investments in unconsolidated entities, financial derivatives–assets, financial derivatives–liabilities, and other secured borrowings, at fair value, respectively. At June 30, 2020, the Company transferred $27.0 million of assets from Level 3 to Level 2 and $130.1 million from Level 2 to Level 3. Transfers between these hierarchy levels were based on the availability of sufficient observable inputs to meet Level 2 versus Level 3 criteria. The leveling of each financial instrument is reassessed at the end of each period, and is based on pricing information received from third-party pricing sources. At June 30, 2020, there was a decrease in the availability of sufficient observable inputs to meet Level 2 criteria due to market volatility, dislocations in the financial markets, and illiquidity, resulting from the effects of the COVID-19 pandemic.
|